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 1 
Abstract 4 
Macrophages are critically involved in wound healing, from dampening inflammation to clearing 5 
cell debris and coordinating tissue repair. Within the wound, the complexity of macrophage 6 
function is increasingly recognized, with adverse outcomes when macrophages are 7 
inappropriately activated, such as in fibrosis or chronic non-healing wounds. Recent advances in 8 
in vivo and translational wound models, macrophage-specific deletions, and new technologies to 9 
distinguish macrophage subsets, have uncovered the vast spectrum of macrophage activation and 10 
effector functions. Here, we summarize the main players in wound healing macrophage 11 
activation and function, including cytokines, apoptotic cells, nucleotides and mechanical stimuli. 12 
We highlight recent studies demonstrating cooperation between these factors for optimal wound 13 
healing. Next, we describe recent technologies such as cell tracking and single cell RNA-seq, 14 
which have uncovered remarkable plasticity and heterogeneity in blood-derived or tissue-15 
resident macrophages and discuss the implications for wound healing. Lastly, we evaluate 16 
macrophage dysfunction in aberrant wound healing that occurs in aging, diabetes and fibrosis. A 17 
better understanding of the longevity and plasticity of wound healing macrophages, and 18 
identification of unique macrophage subsets or specific effector molecules in wound healing, 19 
would shed light on the therapeutic potential of manipulating macrophage function for optimal 20 
wound healing.  21 
 2 
Introduction 22 
Wound healing, which is the repair and restoration of tissue to homeostasis following 23 
injury caused by infection or mechanical trauma, occurs in three main stages: coagulation and 24 
inflammation; resolution of inflammation; and tissue vascularization and regeneration. These 25 
stages are common to all wounds, although the cell-types and secreted factors vary depending on 26 
the organ (e.g. skin, lung, liver, brain) and type of injury (e.g. burn, pathogen). In all wounds, 27 
macrophages are critical players, from contributing to the inflammation necessary to kill 28 
potential pathogens, to resolving inflammation once the pathogens are cleared, and initiating and 29 
maintaining tissue remodeling and regeneration.1 Based on these diverse contributions to wound 30 
healing, macrophages are broadly grouped into three activation types: first, the inflammatory 31 
macrophage for pathogen phagocytosis and killing; second, the resolving macrophage that 32 
removes dead cells and dampens inflammation; third, the tissue remodeling macrophage that 33 
instructs tissue repair. It is important to recognize that these activation phenotypes do not 34 
represent distinct macrophage subsets but likely a continuum of macrophage activation that 35 
changes according to cell ontogeny and environmental stimuli.2  36 
This review will focus on the macrophages that contribute to the final stages of wound 37 
healing, specifically resolution of inflammation mediated by anti-inflammatory macrophages, 38 
and tissue repair, mediated by T helper type 2 (Th2) cytokine-activated ‘M2’ macrophages, also 39 
known as alternatively activated macrophages. We will first describe recently discovered 40 
pathways influencing the activation and function of these cells. Next, we will highlight the 41 
important influence of ontogeny and plasticity on the development of these wound healing 42 
macrophage subsets. Lastly, we will discuss how dysfunctional activation of these cells can 43 
contribute to disease. A better understanding of these wound healing macrophage subsets from 44 
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activation to effector molecules, and whether they can be altered to improve wound healing, 45 
would have significant therapeutic benefit especially since deficient wound healing can be fatal. 46 
Wound healing macrophage activation and function 47 
Numerous soluble and cellular signals instruct macrophage activation for the final stages 48 
of wound healing: tissue remodeling and resolution of inflammation. These include: Th2 49 
cytokines that mediate a tissue remodeling ‘M2’ program, and apoptotic cells that induce an anti-50 
inflammatory macrophage phenotype. We will summarize the main features of these activation 51 
programs and how they act together to promote optimal wound healing. We will also discuss 52 
recently discovered factors that influence these macrophage activation programs.  53 
Th2 Cytokines: M2 macrophages are important players in tissue repair.1 M2 macrophages are 54 
activated by Th2 cytokines, such as IL-4 and IL-13, that are highly produced in allergic 55 
inflammation and helminth infection. For this reason, significant functional information on M2 56 
macrophages has been acquired from helminth infection and allergy studies.3 These studies have 57 
provided insight into the M2-mediated effector pathways for wound healing. Indeed, helminths 58 
are macroscopic organisms that cause tissue injury, and the tissue remodeling that occurs in 59 
allergic responses shares similarities with the tissue repair stage in wound healing. In these 60 
models of tissue injury and inflammation, the Th2 cytokine response is mediated in a two-step 61 
process, as summarized in Figure 1. First, an insult to the barrier causes epithelial cells to release 62 
alarmins, including thymic stromal lymphopoietin (TSLP), IL-25 and IL-33.3 These in turn 63 
activate Th2 cytokine-producing innate cells, such as group 2 innate lymphoid cells, mast cells, 64 
basophils and eosinophils. The critical importance of M2 macrophages in mediating wound 65 
healing is demonstrated in numerous in vitro and in vivo studies. For instance, IL-4/IL-13-66 
activated human THP-1 cells induced proliferation, collagen synthesis and a-smooth muscle 67 
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actin (a-SMA) expression by human dermal fibroblasts (HDFs), in a co-culture assay.4 These 68 
M2-differentiated THP-1 cells also increased dermal fibroblast expression of α-SMA, a feature 69 
of myofibroblasts, indicating that fibroblasts were differentiated into myofibroblasts.4 Further, 70 
abrogation of IL-4Ra signaling in macrophages impaired wound repair in in vivo models of 71 
wound healing by skin punch biopsy, chemical-induced injury or invasive helminth infection-72 
induced injury.5-7 Mechanistically, M2 macrophages initiate wound repair through numerous 73 
pathways including growth factors and matrix metalloproteinases (MMP), summarized in Figure 74 
2 and in recent reviews.1 In addition, M2 macrophage-derived arginase 1 (Arg1) and RELMα 75 
(Retnla) are downstream effectors of wound healing in the skin and following helminth 76 
infection.3, 8 The mechanism by which macrophage-derived arginase promotes skin wound 77 
healing is likely two-fold: dampening inflammation, and promoting matrix deposition through its 78 
metabolism of L-Arginine. RELMa’s effector function in wound healing has recently been 79 
explored.9 RELMα activates the enzyme lysyl hydrolase 2 (Plod2), which mediates optimal 80 
collagen cross-linking.5, 10 Additionally, macrophage-derived RELMa was implicated in 81 
dampening lung inflammation and promoting tissue repair in a model of helminth infection-82 
induced lung injury with rodent hookworm Nippostrongylus brasiliensis.11-13 In this model, gene 83 
expression analysis of RELMa-treated lung macrophages revealed that RELMa promoted 84 
expression of genes involved in extracellular matrix remodeling: matrix metalloproteinase 9 85 
(Mmp9), integrin beta 1 (Itgb1), and junctional adhesion molecule A (F11r).  86 
  IL-4Ra signaling also stimulates tissue-resident macrophage proliferation, which can 87 
have the beneficial outcome of expanding and activating the effector macrophage population for 88 
wound healing.6, 14 Here, additional signals from the tissue environment promoted the IL-4-89 
induced wound healing capacity of M2 macrophages. Specifically, the surfactant protein A (SP-90 
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A) produced in the lung acted through the receptor myosin 18A (Myo18A) to enhance M2 91 
macrophage activation and lung wound healing following N. brasiliensis infection-induced 92 
injury. Interestingly, in the peritoneal cavity, resident macrophages did not respond to SP-A, but 93 
instead were activated by the complement protein C1q, which is structurally homologous to SP-94 
A. The stimulatory effect of C1q on M2 macrophages, likely through Myo18a, was observed in 95 
several tissues including the peritoneal cavity, liver, spleen and adipose tissue. Functionally, C1q 96 
promoted M2 macrophage-mediated liver repair following infection with Listeria 97 
monocytogenes. Whether C1q affects resident tissue macrophage populations, or instead 98 
activates monocytes or macrophages recruited to the injury site from the blood or peritoneal 99 
cavity is unclear. Another study utilizing carbon tetrachloride (CCL4) treatment as a model of 100 
liver injury demonstrated that peritoneal macrophages could cross the mesothelium and penetrate 101 
into the injured liver tissue. These macrophages, originating from the peritoneal cavity, 102 
expressed M2 markers Arginase and RELMa, and exhibited a reparative function when recruited 103 
to the liver.15 While tissue-resident macrophages are likely more rapid responders to injury, 104 
monocytes recruited from the blood can also differentiate into M2 macrophages and contribute to 105 
tissue repair following Schistosoma mansoni infection-induced liver injury.16 This process was 106 
impaired in vitamin A deficient mice suggesting that dietary components are important for 107 
optimal M2 macrophage activation. 108 
 M2 macrophage-mediated killing of large extracellular helminths exhibits common 109 
features of tissue repair. In H. polygyrus infection M2 macrophages are recruited to the helminth, 110 
and produce factors to trap and kill the pathogen.17 The contributing factors that immobilize the 111 
worm include wound healing factors such as arginase 1. Understanding the activation pathway 112 
and effector molecules of M2 macrophages that kill H. polygyrus infection may therefore 113 
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provide insight into new wound healing mechanisms. Mechanistically, recruitment and killing of 114 
H.polygyrus by M2 macrophages involved recognition of helminth antigen-antibody immune 115 
complexes and the production of CXCR2 ligands.18 Mice deficient in FcgR signaling and 116 
activation-induced cytidine deaminase (AID), which contributes to antibody maturation and class 117 
switching, exhibited impaired worm killing but also increased intestinal lesions suggesting 118 
defective wound repair. Further, at later timepoints, Fcrg-/- and Aid-/- mice showed severe 119 
peritonitis that might be attributed to defective lesion repair resulting in increased bacterial 120 
translocation. Investigation of the mechanism of wound repair in this helminth infection model 121 
also revealed the importance of an additional cell-type: the myofibroblast, which was activated 122 
CXCL2 and CXCL3, via CXCR2, and helminth antigens via dectin-2, to mediate wound closure 123 
potentially through expression of a-SMA. Of translational significance, CXCL3 from human 124 
monocyte-derived macrophages induced by Ascaris suum, the pig helminth closely related to the 125 
human parasite Ascaris lumbricoides, up-regulated wound healing by human myofibrobalsts. 126 
These data indicate that crosstalk between M2 macrophages and other cell-types is necessary for 127 
effective wound healing.   128 
Apoptotic cells: A critical step to wound healing is the clearance of apoptotic cells resulting from 129 
the inflammatory environment. This process is mediated by resolving, or resolution, 130 
macrophages. Resolving macrophages sense and phagocytose phostaphatidylserine (PtdSer)-131 
exposed apopotic cells in a process called efferocytosis.19 Effective efferocytosis is dependent on 132 
the receptor tyrosine kinases Axl and Mertk. In addition to clearing dead cells, resolving 133 
macrophages contribute to wound healing and tissue homeostasis by producing anti-134 
inflammatory molecules such as IL-10, and tissue remodeling growth factors such as TGF-b. 135 
Th2 cytokines and apoptotic cell engulfment were originally considered distinct signals, which 136 
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activated M2 or resolving macrophages respectively, however, recent studies have uncovered 137 
synergism of these signals for optimal wound healing. Indeed, co-treatment of bone marrow-138 
derived macrophages with apoptotic neutrophils and Th2 cytokines induced maximal expression 139 
of wound healing genes Retnla (RELMα), Chil3 (Ym1), Ear2 (Eosinophil associated, 140 
ribonuclease A family, member 2), and Fn1 (Fibronectin 1).19 The essential function of apopotic 141 
cell recognition for optimal M2 activation was demonstrated utilizing macrophages deficient in 142 
Axl and Mertk in N. brasiliensis infection as an in vivo model of M2 macrophage-dependent 143 
wound healing.19 Critically, Axl and Mertk functional effects on tissue repair were not restricted 144 
to the lung, as these proteins were required for upregulation of the anti-inflammatory and wound 145 
healing genes in macrophages in the damaged intestine and peritoneal cavity. It has previously 146 
been shown that SP-A induces efferocytosis while C1q activates MERTK expression20, Thus, in 147 
addition to M2 activation, SP-A and C1q might promote apoptotic cell sensing.21 Together, these 148 
studies implicate an inter-dependent, positive feedback loop whereby apoptotic cells and Th2 149 
cytokines act together to promote macrophage-mediated wound healing.   150 
Nucleotides: Macrophage recognition of nucleotides, such as adenosine triphosphate (ATP) and 151 
their metabolites (e.g. adenosine), by P2 and P1 purinergic receptors respectively, influences 152 
their activation and recruitment.22, 23 For instance, ATP released by apoptotic cells promotes 153 
macrophage recruitment and efferocytosis.22 In a mouse model of traumatic brain injury, 154 
microglia chemotaxis towards the localized injury was dependent on extracellular ATP 155 
activation of the P2 receptor P2Y12.24 The P1 purinergic receptors that recognize adenosine also 156 
influence macrophage activation. Specifically, activation of the P1 receptors A2A and A2B 157 
promotes M2 macrophage activation,23 while the A3 receptor signaling induces an anti-158 
inflammatory response.25 Consistent with a tissue protective role for the P1 adenosine receptors, 159 
 8 
A2A receptor-deficient mice exhibit extensive tissue damage and inflammation following 160 
concanavalin A or CCl4-induced liver injury as well as in response to endotoxic shock.26 One 161 
potential mechanism of A2A-mediated tissue protection may be through promoting macrophage 162 
production of IL-10.23 The A2B receptor, which is expressed on macrophages but also non-163 
immune cells such as epithelial cells, also promoted M2 macrophage activation, and was tissue 164 
protective in helminth infection and endotoxin-induced lung injury.27, 28 165 
 MicroRNAs (miRs) also play an important role in macrophage-mediated wound healing 166 
by regulating efferocytosis-mediated suppression of the innate immune response. miR21 was 167 
upregulated in macrophages after efficient efferocytosis where it suppressed pro-inflammatory 168 
TNFα, and induced anti-inflammatory IL-10.29 The mechanism of action of miR21 included 169 
silencing of the signaling molecules PTEN, which contributes to NF-kB-induced inflammation 170 
and TNFa expression, and PDC4, which suppresses IL-10 expression. Together, these studies 171 
identify nucleotides as additional factors that regulate macrophage activation in injury and 172 
inflammation. Regulation of these signals in macrophages may be novel targets to promote 173 
wound healing. 174 
Mechanical stimulus: In addition to soluble factors or cells, tissue structure or physical cues in 175 
the extracellular matrix during wound healing also affects macrophage activation and behavior.30 176 
For instance, macrophage elongation caused by migration in the fibrous tissue of a wound, rather 177 
than in healthy tissue or the vasculature, likely provides different mechanical cues. Recent 178 
studies suggest that these mechanical stimuli regulate macrophage polarization.31 In bone 179 
marrow-derived macrophage shape studies, M1 macrophages, activated by IFNg and LPS, were 180 
flattened and round, while Th2 cytokine-activated M2 macrophages were elongated.31 181 
Conversely, manipulating macrophage cell shape by micropatterning altered expression of 182 
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macrophage phenotype markers. Cell elongation increased expression of M2 markers arginase-1, 183 
CD206, Ym1, characteristic of wound healing macrophages. Moreover, elongation augmented 184 
arginase-1 expression induced by IL-4/IL-13 but decreased inducible nitric oxide synthase 185 
(iNOS) expression caused by IFNγ/LPS, suggesting that cell elongation preferentially skews 186 
macrophages towards an M2 phenotype. The effect of cell elongation on macrophage 187 
polarization was mediated by actin and actin-associated contractility because pharmacological 188 
inhibition of actin and the actin signaling pathway abrogated up-regulation of arginase-1 189 
expression by elongation but not by cytokine stimulation. Hence, polarization induced by 190 
changes in the extracellular matrix structure may promote wound healing through activation of 191 
genes required for tissue repair. In summary, we have highlighted in this section the complexity 192 
of factors that promote wound healing macrophages and have discussed main downstream 193 
macrophage effector pathways, outlined in Figure 1. 194 
Wound healing macrophage heterogeneity and plasticity 195 
 We have summarized thus far multiple studies mapping the wound healing program of 196 
macrophages. Overall, there is a clear consensus that Th2 cytokines and apoptotic cells are key 197 
drivers of wound healing macrophages, but activation can be enhanced or modulated by other 198 
factors. Two active areas of research remain, of relevance to selective treatment strategies to 199 
target wound healing macrophages. First, investigation of the degree of heterogeneity in the 200 
wound healing macrophage subsets would allow for the optimal wound healing profile be 201 
selected and expanded. Second, evaluating the plasticity of the wound healing macrophage 202 
phenotype would guide therapeutic strategies to promote wound healing function. Specifically, 203 
are all macrophages able to differentiate into wound healing macrophages, are they long-lived, 204 
and can they change their phenotype dependent on the microenvironment? Recent research 205 
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technologies including macrophage lineage tracking and single cell profiling have made it 206 
possible to start addressing these questions.  207 
Wound healing macrophage heterogeneity: While original macrophage studies grouped these 208 
cell-types into distinct non-overlapping subsets such as M1, M2 and regulatory macrophages, it 209 
is increasingly apparent that macrophage activation represents a spectrum of phenotypes 210 
dependent on the tissue microenvironment and cell lineage.32 Two main lineages of macrophages 211 
exist: tissue-resident macrophages originating from the embryonic precursors, and monocyte-212 
derived macrophages originating from the bone marrow. The importance of these distinct 213 
macrophage lineages in wound healing is still undefined, however, tissue-resident macrophages 214 
are likely the first responders to wounds. Following injury, tissue-resident macrophages express 215 
adhesion molecules that recruit and guide multiple cell-types.33 Further, tissue-resident 216 
macrophages can replicate to increase their numbers, are highly M2 polarized in response to IL-217 
4, and orchestrate the wound healing stages.34  218 
 Tissue-resident macrophages are long-lived and have the capacity for self-renewal. 219 
Indeed, fate-mapping and parabiosis studies revealed that tissue macrophages such as Kupffer 220 
cells, microglia, alveolar, and peritoneal macrophages are established prenatally and can be 221 
maintained independently of replenishment by blood monocytes under homeostatic conditions.35 222 
In contrast, in the intestine, skin and heart, macrophages are replenished in the steady state by 223 
monocytes. The half-life of intestinal and dermal macrophages was estimated to range from 4 to 224 
6 weeks, while those of the heart ranged from 8 to 12 weeks.36 In contrast to self-renewing 225 
tissue-resident macrophages, monocytes recruited to inflamed tissues cannot maintain 226 
themselves and die once inflammation resolves.35 Given the longevity of tissue-resident 227 
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macrophages, they may consitute a better long-term target for wound healing compared to 228 
monocyte-derived macrophages.  229 
 Tissue-resident macrophage development is governed by distinct groups of transcription 230 
factors. For instance, GATA6 drives peritoneal macrophage differentiation, while PPARg is 231 
involved in alveolar macrophage differentiation.37 With the advent of new technologies such as 232 
single cell RNA-seq (SC-RNA Seq), a more comprehensive identification of tissue macrophage 233 
subsets has been possible. In particular, the transcription factor zinc finger E-box binding 234 
homeobox 2 (ZEB2) was identified as a key determinant of tissue-specific macrophages in 235 
diverse organs including the liver, lung, spleen, brain, and colon.38 In ZEB2 deficient mice, there 236 
was alteration of different tissue-specific macrophage markers, highlighting the technical 237 
difficulty of identifying macrophages within tissues if using limited markers such as CD64 and 238 
F4/80.  239 
 To this end, a study using Single Cell Recognition, a reference-based computational tool 240 
that enables unbiased annotation of SC-RNA Seq, investigated macrophage heterogeneity in lung 241 
fibrosis.39 They characterized three distinct groups of macrophages, including alveolar 242 
macrophages (C1), interstitial macrophages (C3), and an intermediate cluster of cells (C2) in the 243 
lung. Both C2 and C3 were highly enriched in bleomycin-induced fibrosis, and C2 had high 244 
expression of genes from both C1 and C3, indicating that C2 is a transitional state between C1 245 
and C3 in lung fibrosis. CX3CR1 was expressed in both C2 and C3, and these CX3CR1-lineage 246 
cells (CLCs) were increased after injury. MHC II expression was decreased, but expression of 247 
SiglecF, an alveolar macrophage marker, was increased in these cells, indicating that CLCs 248 
transit towards an alveolar macrophage identity. CLCs were in direct contact with fibroblasts 249 
expressing PDGF receptors. The ligand, PDGF, was induced in activated MHC IIhigh alveolar 250 
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macrophages after injury, and conditioned media from MHC IIhigh alveolar macrophages 251 
mediated gap closure by fibroblasts better than media from MHClow alveolar macrophages. Last, 252 
deprivation of CLCs attenuated bleomycin-induced lung fibrosis, implying that CLCs provide 253 
trophic support for fibroblasts in the wound site.  254 
 Diverse macrophage populations were also identified by PrimeFlow, a flow-based 255 
technique which allows RNA cellular profiling of markers that may not have been detectable by 256 
antibodies.40 PrimeFlow analyses of in vitro and in vivo M2-activated macrophages revealed 257 
differential expression of the canonical M2 markers Arg1 and Retnla, with comparable 258 
frequencies of single and double positive subsets.40 Since both these genes contribute to wound 259 
healing, it is likely that targeting the double positive population would be of greatest therapeutic 260 
benefit. Heterogeneity in M2 macrophage subsets was also observed in the human peritoneum. 261 
Patients with peritoneal fibrosis caused by peritoneal dialysis exhibited heterogenous M2 262 
macrophage populations with differential expression of CD163 and CD206.41 The functional 263 
relevance of these subsets in peritoneal fibrosis is unclear, however, high CD163 but not CD206 264 
expression correlated with active peritonitis, and CD163-sorted macrophages produced 265 
chemokine CCL18 and promoted fibroblast proliferation.41 More research is needed to determine 266 
to what extent functional heterogeneity is influenced by macrophage origin versus subtle 267 
differences in the microenvironmental cues. 268 
Wound healing macrophage plasticity: As highlighted previously, macrophages can respond to 269 
a plethora of external cues leading to a wide spectrum of activation phenotypes. Whether these 270 
represent terminally differentiated cells, or whether these cells are plastic and can adapt their 271 
function according to new environmental cues is less clear. Additionally, transcriptional studies 272 
have suggested that the epigenetic landscape may govern macrophage polarization and 273 
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plasticity.37 Within the ever-changing microenvironment of the wound, plasticity and longevity 274 
of the macrophages would be attractive features for therapeutic targeting allowing them to adapt 275 
their function to address the immediate needs within the wound. The monocyte/macrophage 276 
lineage is general recognized as a highly plastic lineage.2 Indeed, more specific research 277 
investigating macrophage plasticity between M1 and M2 macrophages does support a certain 278 
degree of plasticity in M2 macrophages. M2 macrophages that were differentiated following 279 
chronic helminth exposure could respond to M1 activating signals such as LPS and IFNg.42 In an 280 
in vivo co-infection model, peritoneal M2 macrophages activated by H. polygyrus infection were 281 
able to change to antimicrobial nitric oxide-producing M1 macrophages capable of killing an 282 
attenuated Salmonella strain when challenged intraperitoneally.43 In contrast, Salmonella-283 
induced M1 macrophages could not be repolarized by IL-4 treatment, indicating that M1 284 
macrophage activation has a more restrictive effect on plasticity than M2 macrophage 285 
activation.43 These studies show that M2 macrophages have some ability to alter their phenotype 286 
in response to different stimuli. It can be inferred from these studies that wound healing M2 287 
macrophage subsets may be equally plastic, however, further mechanistic investigation in wound 288 
healing models is needed.  289 
 As mentioned above, pro-inflammatory activated M1 macrophages kill pathogens in 290 
wounded tissues, on the other hand, M2 macrophages dampen these inflammatory responses, and 291 
these sequential steps are required for wound healing. AMP-activated protein kinase α1 subunit, 292 
a catalytic domain (AMPKα1) was proven to modulate M1/M2 macrophage polarization.44  293 
Following cardiotoxin injection, AMPKα1 activity was increased in the macrophages recruited 294 
to the regenerating muscle. In both whole body and macrophage-specific Ampkα1-/- mice, there 295 
were more necrotic myofibers than regenerating myofibers following cardiotoxin injection, 296 
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suggesting that AMPKa1 promotes muscle regeneration. Ampkα1-/- macrophages exhibit 297 
preferential expression of  M1 macrophage markers (e.g. iNOS) over M2 markers (e.g. CD206, 298 
CD163, and TGFβ). Since AMPK senses the cellular energy level as ratios of ADP:ATP and 299 
AMP:ATP, this data supports the concept that energy sensing and metabolic activity dictates 300 
macrophage activation.45 Indeed, M2 macrophages exhibit high oxygen consumption rate, that is 301 
impaired in Ampkα1-/- mice. AICAR, a pharmacological AMPK activator, dampened M1 302 
activation and enhanced M2 activation in wild-type but not Ampkα1-/- mice.44 Therefore, 303 
pharmacologically targeting metabolic pathways in wounds may influence macrophage plasticity 304 
and promote a wound healing macrophage subset. 305 
Macrophage function in wound healing disorders 306 
In the previous sections, we have provided evidence supporting the role of macrophages 307 
in the wound healing process. Consistent with their importance in wound healing, impaired or 308 
aberrant macrophages are key features in dysfunctional wounds. In this section, we will describe 309 
wound healing disorders that are mediated by macrophage dysfunction. These include aging and 310 
diabetes, which are associated with deficient wound healing macrophage activation. On the 311 
flipside, excessive wound healing macrophage activation is also detrimental. This is apparent in 312 
fibrotic disorders, which is mediated by uncontrolled M2 macrophage activation. 313 
Aging: Aging can result in immune dysfunction, including immunosenescence, defined as age-314 
related impairments of the immune system,46 and ‘inflamm-aging’, defined as association of 315 
advanced age with chronic low-grade inflammation.47 Both these age-related immune disorders 316 
affect the wound healing process because they can result in impaired pathogen killing, or 317 
conversely, the inappropriate control of inflammation. For instance, monocyte-derived 318 
macrophages from elderly subjects produce less TNFα and IL-6 in response to Streptococcus 319 
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pneumoniae, resulting in hampered bacterial killing compared to young subjects.48 Microarray 320 
analysis of LPS-stimulated macrophages revealed reduced immune response and signal 321 
transduction genes in older mice.49 The deficient activation of macrophages from aged mice 322 
could be attributed to decreased levels of p38 and c-Jun N terminal kinase, which are important 323 
for pro-inflammatory gene expression.50 In addition, A20 that inhibits NF-κB and MAPK 324 
signaling pathways was elevated in the lung and alveolar macrophages of aged mice, which 325 
caused reduced cytokine responses to bacteria.51 Stimulation of alveolar macrophages with 326 
TNFα increased A20 levels, implying the role of TNFα in inflamm-aging.  327 
 Conversely, levels of pro-resolving mediators, such as lipoxins, protectins, maresins, and 328 
the D- or E-series resolvins, are impaired in aged mice. Specifically, aged mice exhibit altered 329 
lipid biosynthesis dynamics with lower level of specialized pro-resolving mediators (SPMs) but 330 
higher levels of pro-inflammatory lipid mediators.52 The phagocytic ability of peritoneal 331 
macrophages is also decreased in aged mice, potentially due to exposure to elevated levels of IL-332 
10 in the peritoneal cavity.46 Of significance to the wound healing process, peritoneal 333 
macrophages from aged mice are less able to phagocytose necrotic cells.53 In response to certain 334 
stimuli, however, macrophages from aged mice remained plastic and were able to respond to 335 
factors in their microenvironment, suggesting that macrophage dysfunction can be reversed. 336 
Indeed, aged macrophages responded to in vitro treatment with IFNγ as effectively as young 337 
macrophages, underscoring the importance of the microenvironment over intrinsic defects.54 338 
Additionally, deficiencies in macrophage polarization in aged mice could be restored with 339 
exercise and diet changes.51, 55  340 
Diabetes: Deficient wound healing is also a severe and potentially fatal consequence of diabetes. 341 
The mechanisms by which diabetics suffer from unhealed chronic wounds are multi-factorial but 342 
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do involve dysfunctional macrophage responses. In particular, macrophage activation via the 343 
nuclear receptor PPARg is impaired in diabetes.56 PPARγ activation promotes wound healing by 344 
decreasing the expression of pro-inflammatory cytokines and increasing wound healing genes.56 345 
The induction of PPARγ activity also leads to granulation tissue formation, angiogenesis, and 346 
collagen deposition that are key for wound repair. In the diabetic wound, the decreased PPARg 347 
activity was caused by sustained production of IL-1β leading to inflammasome activation.56 This 348 
could be reversed by treatment of the wound with PPARg agonists as a promising treatment 349 
strategy to promote wound healing macrophages. 350 
Fibrosis: Optimal wound healing is dependent on a highly regulated M2 macrophage response. 351 
While a deficient M2 macrophage response leads to impaired wound closure, excessive M2 352 
macrophage activation causes scarred or fibrotic tissue.57 In particular, the Th2 cytokine IL-13 353 
can drive pathologic fibrosis through excessive M2 macrophage activation. In models of 354 
helminth-induced fibrosis, the IL-13 driven inflammation and fibrosis were ameliorated with 355 
depletion of CD11b+ macrophages.57 Additionally, in bleomycin-induced pulmonary fibrosis, the 356 
signaling molecule IRAK-M was shown to enhance IL-13 production and fibrosis as IRAK-M-/- 357 
mice had reduced bleomycin-induced collagen accumulation in the lung.58 When lung fibroblasts 358 
were co-cultured with macrophages from bleomycin-treated IRAK-M-/- mice, collagen and α-359 
SMA expression was reduced compared to wild type mice, suggesting that M2 macrophages 360 
were the downstream effectors of IRAK-M signaling in promoting pathologic fibrosis.  361 
 Mincle, a C-type lectin expressed on macrophages, was also identified as a mediator of 362 
fibrosis.59 A high-fat diet increased Mincle expression in macrophages in the crown-like 363 
structures (CLS) of the epididymal fat, which are a characteristic structure in obese adipose 364 
tissue. Mincle was preferentially expressed by CD11b+F4/80lo rather than CD11b+F4/80hi cells. 365 
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These Mincle-expressing macrophages had higher CD11c and lower CD206 expression in line 366 
with previous data showing that it is classically activated macrophages that express Mincle.59 367 
Mincle-/- mice were protected from hepatic steatosis and insulin resistance, associated with 368 
reduced interstitial fibrosis in epididymal fat tissue, α-SMA+ cells and myofibroblasts. 369 
 The beneficial or pathologic effect of M2 macrophages in fibrosis may be critically 370 
dependent on the timing. Using a model of liver fibrosis and spontaneous recovery, where mice 371 
were treated with CCL4 for several weeks then left untreated for the liver to recover, Weng et al. 372 
investigated the function of M2 macrophages.7 Intriguingly, macrophage-specific IL-4Ra-/- mice 373 
were protected from liver fibrosis progression during CCl4 treatment, but had delayed fibrosis 374 
reversal during the recovery phase. The phase-specific function of M2 macrophages was 375 
confirmed with an anti-sense IL-4Ra nucleotide at different timepoints, where it was shown that 376 
early activation of M2 macrophages promotes fibrosis, while at later timepoints, M2 377 
macrophages speed up fibrosis reversal. These studies highlight the importance of tightly 378 
controlling macrophage activation to promote wound healing while circumventing pathologic 379 
fibrosis, summarized in Figure 2. 380 
Conclusion 381 
Macrophages are critical participants in the wound healing process and provide a useful 382 
therapeutic target for wound healing disorders. Indeed, dysfunctional macrophages are key 383 
features of delayed wound healing in aging and diabetes, or excessive wound healing in fibrosis. 384 
There is increasing evidence that macrophages are long-lived and plastic and can change their 385 
phenotype depending on external stimuli. Therefore, it may be possible to skew their function 386 
within the aberrant wound for improved outcomes. While both activating factors and 387 
downstream effectors of wound healing macrophages are well-defined, challenges to 388 
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macrophage-specific wound healing strategies remain. These include the extensive spectrum and 389 
heterogeneity of the macrophage subsets, and the lack of understanding of the individual cues 390 
that can control this heterogeneity. New technologies targeting individual macrophage lineages 391 
and macrophage-derived molecules, as well phenotyping these subsets at the single cell level, 392 
provide the promising prospect that identification of an optimal wound healing macrophage 393 
program of therapeutic potential will soon be possible. 394 
  395 
 19 
References 396 
1. Minutti CM, Knipper JA, Allen JE, Zaiss DM. Tissue-specific contribution of 397 
macrophages to wound healing. Semin Cell Dev Biol 2017; 61: 3-11. 398 
2. Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: 399 
nomenclature and experimental guidelines. Immunity 2014; 41: 14-20. 400 
3. Gause WC, Wynn TA, Allen JE. Type 2 immunity and wound healing: evolutionary 401 
refinement of adaptive immunity by helminths. Nat Rev Immunol 2013; 13: 607-614. 402 
4. Zhu Z, Ding J, Ma Z, Iwashina T, Tredget EE. Alternatively activated macrophages 403 
derived from THP-1 cells promote the fibrogenic activities of human dermal fibroblasts. Wound 404 
Repair Regen 2017; 25: 377-388. 405 
5. Knipper JA, Willenborg S, Brinckmann J, et al. Interleukin-4 receptor α signaling in 406 
myeloid cells controls collagen fibril assembly in skin repair. Immunity 2015; 43: 803-816. 407 
6. Minutti CM, Jackson-Jones LH, García-Fojeda B, et al. Local amplifiers of IL-4Rα-408 
mediated macrophage activation promote repair in lung and liver. Science 2017; 356: 1076-1080. 409 
7. Weng SY, Wang X, Vijayan S, et al. IL-4 receptor alpha signaling through macrophages 410 
differentially regulates liver fibrosis progression and reversal. EBioMedicine 2018; 29: 92-103. 411 
8. Campbell L, Saville CR, Murray PJ, Cruickshank SM, Hardman MJ. Local arginase 1 412 
activity is required for cutaneous wound healing. J Invest Dermatol 2013; 133: 2461-2470. 413 
9. Pine GM, Batugedara HM, Nair MG. Here, there and everywhere: Resistin-like 414 
molecules in infection, inflammation, and metabolic disorders. Cytokine 2018; 110: 442-451. 415 
10. Sutherland TE, Rückerl D, Logan N, Duncan S, Wynn TA, Allen JE. Ym1 induces 416 
RELMα and rescues IL-4Rα deficiency in lung repair during nematode infection. PLoS Pathog 417 
2018; 14: e1007423. 418 
 20 
11. Batugedara HM, Li J, Chen G, et al. Hematopoietic cell-derived RELMα regulates 419 
hookworm immunity through effects on macrophages. J Leukoc Biol 2018; 104: 855-869. 420 
12. Chen G, Wang SH, Jang JC, Odegaard JI, Nair MG. Comparison of RELMα and RELMβ 421 
single- and double-gene-deficient mice reveals that RELMα expression dictates inflammation 422 
and worm expulsion in hookworm infection. Infect Immun 2016; 84: 1100-1111. 423 
13. Nair MG, Herbert DR. Immune polarization by hookworms: taking cues from T helper 424 
type 2, type 2 innate lymphoid cells and alternatively activated macrophages. Immunology 2016; 425 
148: 115-124. 426 
14. Jenkins SJ, Ruckerl D, Cook PC, et al. Local macrophage proliferation, rather than 427 
recruitment from the blood, is a signature of TH2 inflammation. Science 2011; 332: 1284-1288. 428 
15. Wang J, Kubes P. A reservoir of mature cavity macrophages that can rapidly invade 429 
visceral organs to affect tissue repair. Cell 2016; 165: 668-678. 430 
16. Gundra UM, Girgis NM, Gonzalez MA, et al. Vitamin A mediates conversion of 431 
monocyte-derived macrophages into tissue-resident macrophages during alternative activation. 432 
Nat Immunol 2017; 18: 642-653. 433 
17. Esser-von Bieren J, Mosconi I, Guiet R, et al. Antibodies trap tissue migrating helminth 434 
larvae and prevent tissue damage by driving IL-4Rα-independent alternative differentiation of 435 
macrophages. PLoS Pathog 2013; 9: e1003771. 436 
18. Esser-von Bieren J, Volpe B, Sutherland DB, et al. Immune antibodies and helminth 437 
products drive CXCR2-dependent macrophage-myofibroblast crosstalk to promote intestinal 438 
repair. PLoS Pathog 2015; 11: e1004778. 439 
19. Bosurgi L, Cao YG, Cabeza-Cabrerizo M, et al. Macrophage function in tissue repair and 440 
remodeling requires IL-4 or IL-13 with apoptotic cells. Science 2017; 356: 1072-1076. 441 
 21 
20. Greenlee-Wacker MC. Clearance of apoptotic neutrophils and resolution of 442 
inflammation. Immunol Rev 2016; 273: 357-370. 443 
21. Bouchery T, Harris NL. Specific repair by discerning macrophages. Science 2017; 356: 444 
1014. 445 
22. Elliott MR, Chekeni FB, Trampont PC, et al. Nucleotides released by apoptotic cells act 446 
as a find-me signal to promote phagocytic clearance. Nature 2009; 461: 282-286. 447 
23. Csóka B, Selmeczy Z, Koscsó B, et al. Adenosine promotes alternative macrophage 448 
activation via A2A and A2B receptors. FASEB J 2012; 26: 376-386. 449 
24. Haynes SE, Hollopeter G, Yang G, et al. The P2Y12 receptor regulates microglial 450 
activation by extracellular nucleotides. Nat Neurosci 2006; 9: 1512-1519. 451 
25. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS. Inhibition of TNF-452 
alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 1996; 156: 3435-453 
3442. 454 
26. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation 455 
of inflammation and protection from tissue damage. Nature 2001; 414: 916-920. 456 
27. Schingnitz U, Hartmann K, Macmanus CF, et al. Signaling through the A2B adenosine 457 
receptor dampens endotoxin-induced acute lung injury. J Immunol 2010; 184: 5271-5279. 458 
28. Patel N, Wu W, Mishra PK, et al. A2B adenosine receptor induces protective 459 
antihelminth type 2 immune responses. Cell Host Microbe 2014; 15: 339-350. 460 
29. Das A, Ganesh K, Khanna S, Sen CK, Roy S. Engulfment of apoptotic cells by 461 
macrophages: a role of microRNA-21 in the resolution of wound inflammation. J Immunol 2014; 462 
192: 1120-1129. 463 
 22 
30. Van Goethem E, Poincloux R, Gauffre F, Maridonneau-Parini I, Le Cabec V. Matrix 464 
architecture dictates three-dimensional migration modes of human macrophages: differential 465 
involvement of proteases and podosome-like structures. J Immunol 2010; 184: 1049-1061. 466 
31. McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of macrophage 467 
phenotype by cell shape. Proc Natl Acad Sci U S A 2013; 110: 17253-17258. 468 
32. Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of 469 
monocytes. Immunity 2018; 49: 595-613. 470 
33. Kim ND, Luster AD. The role of tissue resident cells in neutrophil recruitment. Trends 471 
Immunol 2015; 36: 547-555. 472 
34. Davies LC, Rosas M, Jenkins SJ, et al. Distinct bone marrow-derived and tissue-resident 473 
macrophage lineages proliferate at key stages during inflammation. Nat Commun 2013; 4: 1886. 474 
35. Hashimoto D, Chow A, Noizat C, et al. Tissue-resident macrophages self-maintain 475 
locally throughout adult life with minimal contribution from circulating monocytes. Immunity 476 
2013; 38: 792-804. 477 
36. Scott CL, Henri S, Guilliams M. Mononuclear phagocytes of the intestine, the skin, and 478 
the lung. Immunol Rev 2014; 262: 9-24. 479 
37. T'Jonck W, Guilliams M, Bonnardel J. Niche signals and transcription factors involved in 480 
tissue-resident macrophage development. Cell Immunol 2018; 330: 43-53. 481 
38. Scott CL, T'Jonck W, Martens L, et al. The transcription factor ZEB2 is required to 482 
maintain the tissue-specific identities of macrophages. Immunity 2018; 49: 312-325.e315. 483 
39. Aran D, Looney AP, Liu L, et al. Reference-based annotation of single-cell 484 
transcriptomes identifies a profibrotic macrophage niche after tissue injury. bioRxiv 2018. 485 
 23 
40. Lai C, Stepniak D, Sias L, Funatake C. A sensitive flow cytometric method for multi-486 
parametric analysis of microRNA, messenger RNA and protein in single cells. Methods 2018; 487 
134-135: 136-148. 488 
41. Bellón T, Martínez V, Lucendo B, et al. Alternative activation of macrophages in human 489 
peritoneum: implications for peritoneal fibrosis. Nephrol Dial Transplant 2011; 26: 2995-3005. 490 
42. Mylonas KJ, Nair MG, Prieto-Lafuente L, Paape D, Allen JE. Alternatively activated 491 
macrophages elicited by helminth infection can be reprogrammed to enable microbial killing. J 492 
Immunol 2009; 182: 3084-3094. 493 
43. Rückerl D, Campbell SM, Duncan S, et al. Macrophage origin limits functional plasticity 494 
in helminth-bacterial co-infection. PLoS Pathog 2017; 13: e1006233. 495 
44. Mounier R, Théret M, Arnold L, et al. AMPKα1 regulates macrophage skewing at the 496 
time of resolution of inflammation during skeletal muscle regeneration. Cell Metab 2013; 18: 497 
251-264. 498 
45. Huang SC, Smith AM, Everts B, et al. Metabolic reprogramming mediated by the 499 
mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity 2016; 500 
45: 817-830. 501 
46. Linehan E, Dombrowski Y, Snoddy R, Fallon PG, Kissenpfennig A, Fitzgerald DC. 502 
Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis. Aging Cell 503 
2014; 13: 699-708. 504 
47. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective 505 
on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254. 506 
 24 
48. Verschoor CP, Johnstone J, Loeb M, Bramson JL, Bowdish DM. Anti-pneumococcal 507 
deficits of monocyte-derived macrophages from the advanced-age, frail elderly and related 508 
impairments in PI3K-AKT signaling. Hum Immunol 2014; 75: 1192-1196. 509 
49. Chelvarajan RL, Liu Y, Popa D, et al. Molecular basis of age-associated cytokine 510 
dysregulation in LPS-stimulated macrophages. J Leukoc Biol 2006; 79: 1314-1327. 511 
50. Boehmer ED, Meehan MJ, Cutro BT, Kovacs EJ. Aging negatively skews macrophage 512 
TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated 513 
pathway. Mech Ageing Dev 2005; 126: 1305-1313. 514 
51. Hinojosa CA, Akula Suresh Babu R, Rahman MM, Fernandes G, Boyd AR, Orihuela CJ. 515 
Elevated A20 contributes to age-dependent macrophage dysfunction in the lungs. Exp Gerontol 516 
2014; 54: 58-66. 517 
52. Arnardottir HH, Dalli J, Colas RA, Shinohara M, Serhan CN. Aging delays resolution of 518 
acute inflammation in mice: reprogramming the host response with novel nano-proresolving 519 
medicines. J Immunol 2014; 193: 4235-4244. 520 
53. Takahashi R, Totsuka S, Ishigami A, Kobayashi Y, Nagata K. Attenuated phagocytosis 521 
of secondary necrotic neutrophils by macrophages in aged and SMP30 knockout mice. Geriatr 522 
Gerontol Int 2016; 16: 135-142. 523 
54. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially 524 
change their functional phenotype in response to changes in microenvironmental influences. J 525 
Immunol 2005; 175: 342-349. 526 
55. Goh J, Ladiges WC. Exercise enhances wound healing and prevents cancer progression 527 
during aging by targeting macrophage polarity. Mech Ageing Dev 2014; 139: 41-48. 528 
 25 
56. Mirza RE, Fang MM, Novak ML, et al. Macrophage PPARγ and impaired wound healing 529 
in type 2 diabetes. J Pathol 2015; 236: 433-444. 530 
57. Borthwick LA, Barron L, Hart KM, et al. Macrophages are critical to the maintenance of 531 
IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol 2016; 9: 38-55. 532 
58. Ballinger MN, Newstead MW, Zeng X, et al. IRAK-M promotes alternative macrophage 533 
activation and fibroproliferation in bleomycin-induced lung injury. J Immunol 2015; 194: 1894-534 
1904. 535 
59. Ichioka M, Suganami T, Tsuda N, et al. Increased expression of macrophage-inducible C-536 
type lectin in adipose tissue of obese mice and humans. Diabetes 2011; 60: 819-826. 537 
  538 
 26 
Authors contributions: SYK and MGN: Concept and design, drafting of the manuscript, figure 539 
design. 540 
Competing interests: The authors have no competing interests to declare. 541 
Acknowledgements: The Nair lab is supported by the NIH (R21AI137830; R21AI135500). We 542 
thank Sarah Bobardt for critical review of the manuscript. 543 
 544 
 545 
 546 
 547 
 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
 557 
 27 
 558 
 559 
 560 
 28 
Figure Legends: 561 
Figure 1. Wound healing macrophage activation. (a) Injury by cuts, chemicals (CCl4 and 562 
bleomycin), helminths or burn injury causes a breach in barrier. (b) The wound healing response 563 
is initiated by dying cells which release cytokines (TSLP, IL-25, and IL-33) that activate Th2 564 
cytokine (IL-4/IL-13) producing cells (blue). Innate cells such as neutrophils (orange) are also 565 
recruited to kill invading pathogens, and apoptose once the challenge is resolved. (c) M2 566 
macrophages (left) are activated by the Th2 cytokines. Equally important is the activation of 567 
resolving macrophages (right) which are activated by phagocytosis of the apoptotic cells 568 
resulting from the inflammation. Rather than distinct subsets, both M2 and resolving 569 
macrophages represent a continuum of macrophage activation that are influenced by both Th2 570 
cytokines and apoptotic cells. 571 
Figure 2. Macrophage enhancers and effectors in wound healing and fibrosis. Wound 572 
healing macrophage activation is enhanced by the following surface markers: (a) signaling 573 
through the Myo18A receptor; (b) FcgR-mediated signaling by immune complexes; (c) ATP or 574 
adenosine binding to purinergic receptors; (d) Mincle surface expression; and intracellular 575 
factor; (e) nuclear receptor PPARg; (f) micro RNA 21. These enhance macrophage effector 576 
function to promote wound healing (green), but if excessive, can lead to fibrosis (brown). 577 
